This application represents a request for an extension of this MERIT Award. The central hypothesis of this award is that glutathione peroxidase-3 (GPx-3) is a principal determinant of extracellular hydrogen peroxide flux from the endothelial cell, and a key regulator of the transmemrane cycling and intracellular actions of hydrogen peroxide. The key scientific accomplishments of this first phase of the award include the identification of essential regulatory determinants of GPx-3, a selenoprotein with complex and unique translational requirements;demonstration of the cofactor activation of GPx-3 catalysis by heparin via a unique polyanionic glycosaminoglycan binding site in the solvent-exposed carboxyterminal tail;the development of a GPx-3 null mouse and the characterization of its vascular and endothelial dysfunction, including a propensity to platelet-dependent thrombosis, the latter recapitulating our work in human populations of subjects with arterial ischemic or cerebral venous strokes;the identification of plasma membrane channels and transporters for hydrogen peroxide and nitric oxide;and the demonstration that mitochondria are a key source of hydrogen peroxide that can be modulated by GPx-3's intracellular counterpart, GPx-1, as well as a unique microRNA, miR210, in part responsible for the Pasteur effect. In this extension of the award, we plan to continue to pursue the same central hypothesis, but will do so in the setting of hypoxia because of the differential effect of hypoxia on GPx-3 (increases) and GPx-1 (decreases), and because of the greater role played by uncoupled mitochondria on hydrogen peroxide production under hypoxic compared with normoxic conditions. We will pursue this goal via three specific aims. First, we will examine the effect of hypoxia on GPx-3 expression, selenium uptake, and the selenoprotein synthesis hierarchy (in renal tubular cells, the primary source of plasma GPx-3 in mammals). Second, we will examine the interactions between GPx-3 and GPx-1 on endothelial hydrogen peroxide production under hypoxic conditions and its consequences for hydrogen peroxide-dependent endothelial signaling. Third, we wll examine the effects of GPx-3 on endothelial function in vivo under hypoxic conditions. These studies should complement prior work conducted during this award, and provide additional useful insights into the role of GPx-3 in the adaptive response to hypoxic stress In the endothelium.
In thls program, we focus on an extracellular enzyme that is a principal regulator of oxidant stress in the vascular compartment, glutathione peroxidase-3. We have studied this molecule across the translational spectrum, having shown its importance as a risk factor for ischemic stroke, now with mechanistic and genetic models supporting this association. We continue to pursue studies of the role of this enzyme in modifying endothelial function under hypoxia, a condition that is common to many vascular diseases with important consequences for endothelial function. These studies should provide unique insights into the regulation of vascular oxidant stress in health and disease.
|Libby, Peter; Loscalzo, Joseph; Ridker, Paul M et al. (2018) Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. J Am Coll Cardiol 72:2071-2081|
|Yang, Jia-Shu; Hsu, Jia-Wei; Park, Seung-Yeol et al. (2018) GAPDH inhibits intracellular pathways during starvation for cellular energy homeostasis. Nature 561:263-267|
|Cranford, Jonathan P; O'Hara, Thomas J; Villongco, Christopher T et al. (2018) Efficient Computational Modeling of Human Ventricular Activation and Its Electrocardiographic Representation: A Sensitivity Study. Cardiovasc Eng Technol 9:447-467|
|Musri, Melina M; Coll-Bonfill, Núria; Maron, Bradley A et al. (2018) MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling. Am J Respir Cell Mol Biol 59:490-499|
|Wang, Rui-Sheng; Loscalzo, Joseph (2018) Network-Based Disease Module Discovery by a Novel Seed Connector Algorithm with Pathobiological Implications. J Mol Biol 430:2939-2950|
|Leopold, Jane A; Loscalzo, Joseph (2018) Emerging Role of Precision Medicine in Cardiovascular Disease. Circ Res 122:1302-1315|
|Samokhin, Andriy O; Stephens, Thomas; Wertheim, Bradley M et al. (2018) NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med 10:|
|Cheng, Feixiong; Desai, Rishi J; Handy, Diane E et al. (2018) Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun 9:2691|
|Oldham, William M; Oliveira, Rudolf K F; Wang, Rui-Sheng et al. (2018) Network Analysis to Risk Stratify Patients With Exercise Intolerance. Circ Res 122:864-876|
|Pang, Paul; Abbott, Molly; Abdi, Malyun et al. (2018) Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function. Nephrol Dial Transplant 33:923-934|
Showing the most recent 10 out of 117 publications